NEW YORK (TheStreet) -- Shares of Fitbit  (FIT) were plummeting 30.60% to $8.89 in after-hours trading on Wednesday after reporting 2016 third-quarter revenue below analysts' expectations and guiding for fourth-quarter and full-year earnings and revenue well below consensus estimates. 

After the market close, the San Francisco-based maker of wearables said third-quarter revenue grew 23% year-over-year to $503.8 million, but missed analysts' estimates of $506.9 million. 

Adjusted earnings of 19 cents per share met analysts' estimates. 

Fitbit anticipates current-quarter adjusted earnings between 14 cents and 18 cents per share on revenue between $725 million and $750 million. Analysts surveyed by FactSet are looking for adjusted earnings of 75 cents per share and $985 million in revenue.

For the full year, Fitbit expects to report adjusted earnings between 55 cents and 59 cents per share on revenue between $2.32 billion and $2.35 billion. The FactSet consensus is for adjusted earnings of $1.18 per share on revenue of $2.58 billion for the year.

Separately, TheStreet Ratings team rates the stock as a "sell" with a ratings score of D+.

Fitbit's weaknesses include its unimpressive growth in net income over time.

You can view the full analysis from the report here: FIT

TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. 

More from Markets

Dow Sells Off as U.S. and China Trade Tensions Escalate

Dow Sells Off as U.S. and China Trade Tensions Escalate

China Central Bank Governor Says Stay 'Calm and Rational' After Market Free Fall

China Central Bank Governor Says Stay 'Calm and Rational' After Market Free Fall

Here Is Your Market Playbook During This Tariff-Driven Selloff

Here Is Your Market Playbook During This Tariff-Driven Selloff

FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff

AT&T-Time Warner Ruling Could Usher in More Healthcare Deals

AT&T-Time Warner Ruling Could Usher in More Healthcare Deals